OMIC logo

OMIC

Profile

Full Name

Singular Genomics Systems, Inc.

Ticker Symbol

OMIC

Exchange

NASDAQ

Sector

Healthcare

Industry

Medical Instruments & Supplies

Country

United States

IPO

May 27, 2021

Indexes

Not included

Website

http://www.singulargenomics.com

Employees

255

Key Details

Price

-

Market cap

-

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$2.91M(+280.52% YoY)

Annual EPS

-$39.00(-1.56% YoY)

PE ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

-
OMIC price value is unknown

30-Day Relative Volume

-
OMIC 30-day relative volume value is unknown

Price Performance

Price Most recent change

-
OMIC price change on Jan 1, 1 is unknown

Price YTD change

-
OMIC price ytd change is unknown

Price 1-year change

-
OMIC price 1-year change is unknown

Price 3-year change

-
OMIC price 3-year change is unknown

Price Range

Price All-time high

$935.10
OMIC price is currently at an all-time high

Price 3-year low

$0.30
OMIC price is currently at its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

-
OMIC market capitalization value is unknown

Market cap 3-year change

-
OMIC market capitalization 3-year change is unknown

Market cap All-time high

$2.21B
OMIC market capitalization is currently at an all-time high

Market cap sector rank

-
OMIC market capitalization is unknown

Shares Outstanding

Shares Outstanding 1-Year Change

+1.74%
OMIC shares outstanding is up +1.74% year-on-year

Shares Outstanding 3-Year Change

+6.87%
OMIC shares outstanding is up +6.87% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

-
OMIC beta value is unknown

200-day SMA

-
OMIC SMA 200 is unknown

50-day SMA

-
OMIC SMA 50 is unknown

RSI

-
OMIC 14-day relative strength index value is unknown

Volume

-
OMIC 30-day relative volume value is unknown

ATR

-
OMIC average true range value is unknown

10-day Historical Volatility

-
OMIC 10-day historical volatility value is unknown

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$2.91M
OMIC annual revenue is $2.91 million

Revenue Analysts estimate

$3.35M
OMIC annual revenue is currently -13.21% lower than the consensus analysts' forecast

Revenue 1-year change

+280.52%
OMIC annual revenue is up +280.52% year-on-year

Revenue Sector rank

-
OMIC annual revenue is unknown

EPS

EPS

-$39.00
OMIC annual earnings per share is -$39.00

EPS Analysts estimate

-$34.45
OMIC annual earnings per share is currently +13.21% higher than the consensus analysts' forecast

EPS 1-year change

-1.56%
OMIC annual earnings per share is down -1.56% year-on-year

EPS Sector rank

-
OMIC annual earnings per share is unknown

Profit

Gross profit

-$558.00K
OMIC annual gross profit is -$558.00 thousand

Gross margin

-19.17%
OMIC annual gross profit margin is -19.17%

Operating profit

-$102.80M
OMIC annual operating income is -$102.80 million

Operating margin

-3531.47%
OMIC annual operating profit margin is -3531.47%

Net income

-$94.82M
OMIC annual net profit is -$94.82 million

Net margin

-3257.30%
OMIC annual net profit margin is -3257.30%

Expenses

Total expenses

$105.71M
OMIC annual total expenses is $105.71 million

Operating expenses

$102.24M
OMIC annual total operating expenses is $102.24 million

Cost of goods sold

$3.47M
OMIC annual cost of goods sold is $3.47 million

Selling, general & administrative expenses

$54.48M
OMIC annual SGA is $54.48 million

Depreciation and amortization

$7.22M
OMIC annual depreciation & amortization is $7.22 million

Interest expense

$1.10M
OMIC annual interest expense is $1.10 million

Income tax

-
OMIC annual income tax value is unknown

EBIT & EBITDA

EBIT

-$93.72M
OMIC annual earnings before interest & taxes is -$93.72 million

EBITDA

-$86.50M
OMIC annual EBITDA is -$86.50 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$265.47M
OMIC annual total assets is $265.47 million

Non current assets

$73.24M
OMIC annual long term assets is $73.24 million

Current assets

$192.23M
OMIC annual total current assets is $192.23 million

Cash and cash equivalents

$16.23M
OMIC annual cash & cash equivalents is $16.23 million

Accounts receivable

$565.00K
OMIC annual accounts receivable is $565.00 thousand

Inventory

$13.57M
OMIC annual inventory is $13.57 million

Liabilities

Total liabilities

$86.46M
OMIC annual total liabilities is $86.46 million

Long term liabilities

$68.17M
OMIC annual total long term liabilities is $68.17 million

Current liabilities

$18.29M
OMIC annual total current liabilities is $18.29 million

Accounts payable

$2.59M
OMIC annual accounts payable is $2.59 million

Debt

Total debt

$75.29M
OMIC annual total debt is $75.29 million

Total debt 1-year change

+27.95%
OMIC annual total debt is up +27.95% year-on-year

Long term debt

$67.52M
OMIC annual long term debt is $67.52 million

Short term debt

$7.76M
OMIC annual short term debt is $7.76 million

Equity & Capital

Shareholders equity

$179.01M
OMIC annual stockholders equity is $179.01 million

Book value

$179.01M
OMIC annual book value is $179.01 million

Retained earnings

-$337.60M
OMIC annual retained earnings is -$337.60 million

Working capital

$173.94M
OMIC annual working capital is $173.94 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$73.65M
OMIC annual cash flow from operations is -$73.65 million

Cash from operations 1-year change

+15.44%
OMIC annual cash flow from operations is up +15.44% year-on-year

Cash from investing

$13.81M
OMIC annual cash flow from investing activities is $13.81 million

Cash from investing 1-year change

+134.9%
OMIC annual cash flow from investing activities is up +134.9% year-on-year

Cash from financing

$696.00K
OMIC annual cash flow from financing activities is $696.00 thousand

Cash from financing 1-year change

-22.75%
OMIC annual cash flow from financing activities is down -22.75% year-on-year

CAPEX

CAPEX

$970.00K
OMIC annual capital expenditures is $970.00 thousand

CAPEX 1-year change

-83.89%
OMIC annual capital expenditures is down -83.89% year-on-year

Free Cash Flow

Free cash flow

-$74.62M
OMIC annual free cash flow is -$74.62 million

Free cash flow 1-year change

+19.87%
OMIC annual free cash flow is up +19.87% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-19.17%
OMIC annual gross profit margin is -19.17%

Operating margin

-3531.47%
OMIC annual operating profit margin is -3531.47%

Net margin

-3257.30%
OMIC annual net profit margin is -3257.30%

ROA & ROE

ROA

-31.96%
OMIC annual return on assets is -31.96%

ROE

-43.17%
OMIC annual return on equity is -43.17%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
OMIC price to earnings ratio value is unknown

PE ratio Sector rank

-
OMIC price to earnings ratio is unknown

PB Ratio

PB ratio

-
OMIC price to book ratio value is unknown

PB ratio Sector rank

-
OMIC price to book ratio is unknown

PS Ratio

PS ratio

-
OMIC price to sales ratio value is unknown

PS ratio Sector rank

-
OMIC price to sales ratio is unknown

Enterprise value

Enterprise value

-
OMIC enterprise value value is unknown

Enterprise value Sector rank

-
OMIC enterprise value is unknown

EV/EBITDA

EV/EBITDA

-
OMIC EV/EBITDA value is unknown

EV/EBITDA Sector rank

-
OMIC EV/EBITDA is unknown

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

10.51
OMIC annual current ratio is 10.51

Quick ratio

9.77
OMIC annual quick ratio is 9.77

Leverage

Debt to equity

0.05
OMIC annual debt to equity ratio is 0.05

Interest coverage ratio

-85.12
OMIC annual interest coverage ratio is -85.12

Risk & Stability

Piotroski F-Score

2
OMIC piotroski f-score is 2

Altman Z-Score

-
OMIC altman z-score value is unknown

Analyst ratings

Recent major analysts updates

Jul 9, 24 Goldman Sachs
Neutral
May 15, 24 Goldman Sachs
Neutral
Mar 20, 24 UBS
Neutral
Jan 23, 24 Goldman Sachs
Neutral
Jan 22, 24 Goldman Sachs
Neutral
Aug 10, 23 Goldman Sachs
Neutral
Nov 8, 22 Goldman Sachs
Neutral
Aug 17, 22 UBS
Neutral
Aug 10, 22 Goldman Sachs
Neutral
Aug 10, 22 B of A Securities
Underperform

Institutional Ownership

Similar stocks

  • What is the ticker symbol for Singular Genomics Systems?
  • Does Singular Genomics Systems pay dividends?
  • What sector is Singular Genomics Systems in?
  • What industry is Singular Genomics Systems in?
  • What country is Singular Genomics Systems based in?
  • When did Singular Genomics Systems go public?
  • Is Singular Genomics Systems in the S&P 500?
  • Is Singular Genomics Systems in the NASDAQ 100?
  • Is Singular Genomics Systems in the Dow Jones?
  • When was Singular Genomics Systems's last earnings report?
  • When does Singular Genomics Systems report earnings?
  • Should I buy Singular Genomics Systems stock now?

What is the ticker symbol for Singular Genomics Systems?

The ticker symbol for Singular Genomics Systems is NASDAQ:OMIC

Does Singular Genomics Systems pay dividends?

No, Singular Genomics Systems does not pay dividends

What sector is Singular Genomics Systems in?

Singular Genomics Systems is in the Healthcare sector

What industry is Singular Genomics Systems in?

Singular Genomics Systems is in the Medical Instruments & Supplies industry

What country is Singular Genomics Systems based in?

Singular Genomics Systems is headquartered in United States

When did Singular Genomics Systems go public?

Singular Genomics Systems's initial public offering (IPO) was on May 27, 2021

Is Singular Genomics Systems in the S&P 500?

No, Singular Genomics Systems is not included in the S&P 500 index

Is Singular Genomics Systems in the NASDAQ 100?

No, Singular Genomics Systems is not included in the NASDAQ 100 index

Is Singular Genomics Systems in the Dow Jones?

No, Singular Genomics Systems is not included in the Dow Jones index

When was Singular Genomics Systems's last earnings report?

Singular Genomics Systems's most recent earnings report was on Mar 18, 2025

When does Singular Genomics Systems report earnings?

The date for Singular Genomics Systems's next earnings report has not been announced yet

Should I buy Singular Genomics Systems stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page